A Study of Florbetapir (18F) in Japanese Healthy Volunteers

NCT01660815 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: florbetapir (18F)

Sponsor

Avid Radiopharmaceuticals

Collaborators

[object Object]